Description
Title: Effectiveness, safety, and practical considerations of the drug nintedanib in the treatment of idiopathic pulmonary fibrosis
Abstract: Idiopathic pulmonary fibrosis (IPF) is a chronic condition with a poor prognosis and a progressive course. Antifibrotic medications offer a chance to slow the disease’s progression and improve the quality of life for IPF patients. Nintedanib, an oral yrosine kinase inhibitor, is one of these medications. The reader can find a summary of the most recent research on the effectiveness and safety of treating IPF patients with nintedanib in the article that follows. This study makes use of information from pivotal studies and clinical practice to show a variety of potential uses for the drug in IPF patients.
Keywords: idiopathic pulmonary fibrosis; antifibrotic treatments; nintedanib; effectiveness; safety; clinical practice
Paper Quality: SCOPUS / Web of Science Level Research Paper
Subject: Advances in Respiratory Medicine
Writer Experience: 20+ Years
Plagiarism Report: Turnitin Plagiarism Report will be less than 10%
Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.
What will I get after the purchase?
A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.
In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915
Reviews
There are no reviews yet.